oritavancin structure
|
Common Name | oritavancin | ||
|---|---|---|---|---|
| CAS Number | 171099-57-3 | Molecular Weight | 1793.10000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C86H97Cl3N10O26 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of oritavancinOritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2]. |
| Name | oritavancin |
|---|---|
| Synonym | More Synonyms |
| Description | Oritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C86H97Cl3N10O26 |
|---|---|
| Molecular Weight | 1793.10000 |
| Exact Mass | 1790.56000 |
| PSA | 560.98000 |
| LogP | 8.57000 |
| Hazard Codes | Xn |
|---|
| LY333328 |
| Orbactiv |